Wegovy insurance guide

Does Insurance Cover Wegovy in 2026?

A medically reviewed guide to Wegovy coverage requirements, costs, prior authorization, denials, appeals, and approval tips.

Reviewed & Approved By
Dr. Fremlin Dekyi, MD

Dr. Fremlin Dekyi, MD

Board-certified Family Medicine Physician

Medical Reviewer, Doko Medical

  • Evidence-Based Review
  • Clinical Accuracy Verified
  • Reviewed for Wegovy Coverage Education
Does Insurance Cover Wegovy in 2026?
Medical Review Statement

This article has been medically reviewed and approved by Dr. Fremlin Dekyi, MD, to support clinical accuracy and patient-friendly education about Wegovy insurance coverage. This content is educational and does not replace personalized medical advice, diagnosis, treatment, or insurance benefit verification.

Quick Answer

Does insurance cover Wegovy in 2026?

Many insurance plans may cover Wegovy in 2026, but approval depends on the individual plan, employer benefits, medical history, BMI, formulary rules, and clinical requirements. Prior authorization is commonly required.

Coverage is plan-specific. Some eligible patients can substantially reduce their out-of-pocket expense after approval, while other plans exclude anti-obesity medication entirely.

This guide explains how Wegovy works, who may qualify, what insurers commonly request, expected costs, and practical steps after a denial.

Clinical Evidence

Clinical Evidence: Does Wegovy Actually Work?

Strong clinical evidence supporting semaglutide for chronic weight management is one reason insurers continue to evaluate Wegovy coverage.

Evidence From the STEP Clinical Trials

The STEP clinical trial program evaluated semaglutide in adults with obesity or overweight. Participants receiving semaglutide achieved substantially greater average weight loss than those receiving placebo.

Trials also reported improvements in waist circumference and several cardiometabolic measures. Results vary, and Wegovy is intended for use with reduced-calorie nutrition and increased physical activity.

  • Significant average weight reduction
  • Improvement in waist circumference
  • Improvement in blood sugar and cardiometabolic measures
  • Benefits sustained during continued treatment

What Is Wegovy?

Wegovy is an FDA-approved prescription medication for chronic weight management in eligible adults with obesity and certain adults with overweight and a weight-related condition.

Its active ingredient is semaglutide, a GLP-1 receptor agonist that can reduce appetite, increase fullness, slow stomach emptying, and help reduce calorie intake when combined with lifestyle changes.

Does Insurance Cover Wegovy in 2026?

Many plans may cover Wegovy, but coverage is not guaranteed. It depends on the specific health plan, employer-selected benefits, pharmacy formulary, medical necessity rules, and prior authorization criteria.

Some plans offer substantial coverage, while others exclude anti-obesity medications as a benefit category.

Which Types of Insurance May Cover Wegovy?

Coverage differs among commercial plans and government programs.

Employer-Sponsored Health Plans

Employer plans are a common source of coverage. Benefits depend on employer selections, pharmacy benefit policies, formulary placement, and authorization rules. Some employers exclude anti-obesity medication because of cost concerns.

Individual Marketplace Plans

ACA marketplace coverage varies by state, insurer, and plan design. Patients should review the current prescription formulary before assuming Wegovy is covered.

Medicare

Medicare coverage for anti-obesity medications remains limited and continues to evolve. Patients should verify current benefits and indication-specific rules directly with their plan.

Medicaid

Medicaid coverage varies by state. Some state programs cover obesity medications, while others maintain restrictions or exclusions.

Why Insurers Require Wegovy Prior Authorization

Prior authorization lets the insurer confirm that Wegovy is medically necessary, the patient meets its criteria, benefit requirements are satisfied, and treatment aligns with accepted clinical guidance.

What Is Included in a Wegovy Prior Authorization?

A complete request commonly includes the following information.

Patient and Diagnosis Information

Height, weight, BMI, medical history, and documentation of obesity or overweight are commonly required.

Weight-Related Conditions

Relevant conditions may include hypertension, sleep apnea, prediabetes, type 2 diabetes, or dyslipidemia.

Previous Weight Loss Attempts

Insurers may request evidence of nutrition changes, exercise programs, behavioral interventions, or structured weight-management programs.

Provider Documentation

Clinical notes, relevant diagnoses, treatment recommendations, and a medical-necessity explanation may support the submission.

Who May Qualify for Insurance-Covered Wegovy?

Plan rules vary, but many use criteria similar to FDA-approved prescribing guidelines.

BMI of 30 or Higher

Adults with obesity may qualify based partly on BMI, subject to all other plan requirements.

BMI of 27 or Higher With a Weight-Related Condition

Adults with overweight may qualify when they also have a condition such as hypertension, sleep apnea, prediabetes, or dyslipidemia.

Medical Necessity Review

Insurers may also assess health risks, previous treatments, clinical appropriateness, and benefit exclusions. BMI alone does not guarantee approval.

Common Reasons Wegovy Coverage Is Denied

Common reasons include an anti-obesity medication exclusion, missing records, failure to meet BMI criteria, an incomplete prior authorization, or unmet step-therapy requirements. The denial notice should explain whether and how the decision may be appealed.

How Much Does Wegovy Cost With Insurance?

Cost depends on the plan, deductible, medication tier, copay or coinsurance, and pharmacy network. Some covered patients may pay less than $50 monthly, while others may pay between $50 and $300 or more. High-deductible plan members may initially owe more.

These are only examples, not guaranteed prices. Patients should verify the current amount with their insurer and pharmacy.

How Much Does Wegovy Cost Without Insurance?

Without coverage, Wegovy may cost several hundred dollars or more per month. Pricing depends on the pharmacy, dose, region, and eligibility for current manufacturer programs. Patients should verify current pricing and long-term affordability before treatment.

Which Insurance Companies May Cover Wegovy?

Depending on the plan, coverage may be available through Aetna, UnitedHealthcare, Blue Cross Blue Shield organizations, Cigna, Humana, or regional insurers.

The insurer’s name alone does not determine coverage. Two members with the same carrier may have different benefits because of employer selections or plan design.

Insurance May Cover Wegovy Prior Auth
Aetna Often Yes
BCBS Varies Often
UHC Varies Often
Cigna Varies Often

How to Check Your Wegovy Coverage

Use current plan documents and ask medication-specific questions.

Step 1: Review the Formulary

Search for Wegovy in the plan’s current prescription drug list.

Step 2: Check Coverage Restrictions

Look for prior authorization, step therapy, quantity limits, and anti-obesity medication exclusions.

Step 3: Contact Member Services

Ask whether Wegovy is covered, its tier, the authorization criteria, and expected copay or coinsurance.

Step 4: Speak With Your Provider

A provider can evaluate clinical eligibility and prepare documentation required by the plan.

What Happens After Prior Authorization Is Submitted?

The insurer reviews eligibility, medical necessity, clinical records, and plan requirements. It may approve coverage, request more information, or deny the request. Patients should carefully review any denial notice and appeal instructions.

Can You Appeal a Wegovy Denial?

Yes, when the plan provides appeal rights. An appeal may include updated BMI records, relevant diagnoses, additional medical records, and a provider letter explaining medical necessity. A complete appeal may address the denial reason, but approval is not guaranteed.

Is Wegovy Worth It If Insurance Covers It?

Coverage may make Wegovy more affordable for an eligible patient. Potential benefits include meaningful weight loss and improvement in metabolic health or obesity-related risks. A qualified clinician should review benefits, risks, contraindications, and long-term treatment needs.

Wegovy Prior Authorization: Step-by-Step Approval Process

Prior authorization allows an insurer to confirm that Wegovy is medically necessary and that a patient meets the plan’s criteria. Preparing complete information can help avoid preventable delays.

Step 1: Medical Evaluation

A healthcare provider reviews weight, height, BMI, medical history, weight-related conditions, previous weight loss attempts, and current medications to determine whether Wegovy may be clinically appropriate.

Step 2: Documentation Collection

The care team gathers BMI and weight history, an obesity diagnosis, relevant blood-pressure or sleep-apnea records, prediabetes documentation, and laboratory results when clinically relevant.

Step 3: Prior Authorization Submission

The provider submits clinical notes, diagnosis codes, BMI records, previous treatment history, and a medical-necessity explanation through the insurer’s required process.

Step 4: Insurance Review

The insurer reviews coverage eligibility, medical necessity, plan benefits, formulary status, and authorization criteria. Review times vary.

Step 5: Additional Information Requests

The plan may ask for updated measurements, additional notes, prior diet-program records, or clarification of medical necessity. Prompt responses can keep the review moving.

Step 6: Approval, Conditional Approval, or Denial

Approval authorizes coverage under plan benefits. Conditional approval may be limited to a set period. A denial means current requirements were not met or the benefit is excluded.

Step 7: Appeals Process

An appeal may add medical records, updated BMI information, obesity-related diagnoses, and a provider letter that responds directly to the denial reason. Approval is not guaranteed.

Step 8: Ongoing Reauthorization

Some plans periodically request evidence of continued use, clinical benefit, weight-loss progress, or ongoing provider supervision. Knowing renewal requirements may help prevent interruptions.

Wegovy vs Zepbound Insurance Coverage

Both medications may be covered, but their formulary placement, approval requirements, and patient costs are not always identical. Coverage for one does not guarantee coverage for the other.

Similarities

Plans commonly consider prior authorization, BMI, medical necessity, weight-related conditions, and previous treatment attempts for both medications.

Formulary and Authorization Differences

One medication may be preferred, have a lower tier, require different records, or follow different reauthorization and step-therapy rules. Formularies can change.

Cost Comparison

Deductibles, copays, coinsurance, formulary tiers, pharmacy networks, and employer benefits determine which medication costs less under a particular plan.

Which Medication Is Easier to Get Covered?

There is no universal answer. Patients should verify current benefits for the prescribed medication and discuss clinical fit with their provider.

Feature Wegovy Zepbound
Active Ingredient Semaglutide Tirzepatide
FDA Approved for Weight Loss Yes Yes
Prior Authorization Common Yes Yes
Covered by Some Commercial Plans Yes Yes
Employer Coverage Varies Yes Yes
BMI Documentation Often Required Yes Yes
Appeal Available if Denied Usually Usually

Does Aetna Cover Wegovy?

Aetna may cover Wegovy for eligible members when anti-obesity medication is included in the specific plan’s formulary. Coverage varies by employer benefits and plan design, and prior authorization is commonly required.

A plan may use BMI 30 or higher, or BMI 27 or higher with a condition such as hypertension, sleep apnea, prediabetes, type 2 diabetes, or high cholesterol, as part of its criteria. It may also request records of previous lifestyle or weight-management efforts.

Self-funded employers can establish their own pharmacy benefits, so two Aetna members may have different coverage. Members should verify their current formulary and benefit documents before treatment.

Common Aetna Documentation

The provider may need to submit medical records, current BMI, weight history, relevant diagnoses, previous treatment efforts, and an explanation of medical necessity.

Common Aetna Denial Reasons

Potential reasons include a plan exclusion, missing authorization records, unmet BMI criteria, missing documentation of a qualifying condition, or unmet step-therapy rules. When appeal rights exist, additional clinical evidence may be submitted.

Does Blue Cross Blue Shield (BCBS) Cover Wegovy?

Coverage varies substantially because BCBS operates through independent regional organizations. A plan in one state or employer group may cover Wegovy while another excludes anti-obesity medication.

Plans that cover Wegovy may require prior authorization using BMI, weight-related conditions, previous weight loss efforts, and provider documentation. Some plans also request periodic follow-up and evidence of clinical benefit for continued coverage.

Common BCBS Documentation

Requests may include current BMI, weight history, relevant medical records, previous weight-management efforts, and a provider assessment of medical necessity.

Common BCBS Denial Reasons

Potential reasons include an employer exclusion, incomplete authorization, unmet BMI criteria, or missing supporting records. Members should use the appeal instructions provided by their specific regional plan.

Does UnitedHealthcare (UHC) Cover Wegovy?

UnitedHealthcare may cover Wegovy under some commercial plans, depending on the formulary, employer benefits, and authorization rules. Prior authorization is common.

A plan may assess BMI 30 or higher, or BMI 27 or higher with a qualifying condition, along with previous nutrition, exercise, or behavioral interventions. Coverage can differ between members because employers select different benefits.

Common UHC Documentation

The request may include height, weight, BMI, medical history, obesity-related diagnoses, previous treatment records, and the prescriber’s treatment rationale.

Common UHC Denial Reasons

Potential reasons include a weight-loss medication exclusion, missing records, unmet BMI criteria, or incomplete forms. An appeal may add evidence that directly addresses the denial reason.

Does Cigna Cover Wegovy?

Cigna may cover Wegovy when the medication is included in the plan and clinical requirements are met. Employer-sponsored benefit choices can produce substantial differences among Cigna-administered plans.

Plans may consider BMI 30 or higher, or BMI 27 or higher with hypertension, high cholesterol, sleep apnea, prediabetes, or another qualifying condition. Previous weight-management efforts may also be requested.

Common Cigna Documentation

The provider may submit BMI and weight history, medical records, obesity-related diagnoses, previous treatment efforts, and a treatment plan supporting medical necessity.

Common Cigna Denial Reasons

Potential reasons include plan exclusions, insufficient records, unmet BMI requirements, or missing authorization information. Members may be able to appeal with additional evidence under their plan’s rules.

Employer insurance remains a major potential source of Wegovy coverage. Employers balance pharmacy expense against possible effects on long-term health, healthcare use, and employee productivity.

Why Employers May Expand Coverage

Obesity is associated with diabetes, cardiovascular disease, sleep apnea, hospital use, and other healthcare needs. Some employers view treatment as a preventive-health investment.

Why Some Employers Still Exclude Wegovy

Pharmacy costs, budget constraints, benefit priorities, and uncertainty about long-term utilization can lead employers to exclude anti-obesity medication.

What Employees Can Do

Employees can contact Human Resources, participate in benefit surveys, request obesity-treatment coverage, and compare available plans during enrollment. Benefits may change annually.

Illustrative Wegovy Coverage Scenarios

These hypothetical examples explain how plan design and documentation may affect a decision. They are not identifiable patients or guarantees of coverage.

Scenario 1: Employer Plan Approval

An adult with a BMI of 37 and hypertension has a plan including obesity medication. BMI, blood-pressure, and weight-management records support review.

Scenario 2: Denial Followed by Appeal

An adult with a BMI of 33 and sleep apnea receives a denial for incomplete records. The appeal adds diagnosis records, provider notes, and a medical-necessity letter.

Scenario 3: Plan-Wide Exclusion

An adult meets clinical prescribing criteria, but the employer plan excludes anti-obesity medication. Clinical eligibility alone does not create an insurance benefit.

Scenario 4: Marketplace Plan Review

An adult with a BMI of 29 and prediabetes has a marketplace plan that includes qualifying obesity treatment. The insurer reviews authorization records and relevant laboratory results.

Wegovy Savings Card and Manufacturer Assistance

Manufacturer programs may offer eligible patients reduced copays, temporary pricing, financial assistance, or other savings. Eligibility, restrictions, and offers change, and government-insured patients may be excluded from some programs. Patients should review current terms directly with the manufacturer before relying on estimated savings.

Key Wegovy coverage takeaways

  • Coverage depends on the specific plan and employer benefit design.
  • Prior authorization and complete medical documentation are common.
  • Many plans use BMI 30+, or BMI 27+ with a qualifying condition, as part of their criteria.
  • A denial may be appealable when additional records address the stated reason.
  • Current benefits and prices should be verified directly with the insurer and pharmacy.
Best next step

Use consultation to turn search intent into a real treatment decision

Patients usually get more value from medical review, fit assessment, and follow-up planning than from choosing a medication based only on headlines or social posts.

Frequently asked questions

Many commercial plans may provide coverage, but requirements and exclusions vary by plan.

Many insurers require prior authorization before approving coverage.

Many plans use BMI 30 or higher, or BMI 27 or higher with a qualifying weight-related condition, along with other criteria.

Cost depends on the plan, deductible, medication tier, copay or coinsurance, and pharmacy benefits.

Coverage is limited and indication-specific rules continue to evolve. Verify current benefits directly with Medicare and the drug plan.

Coverage varies by state Medicaid program.

Review the denial reason and ask your provider whether an appeal with additional documentation is appropriate.

Some employer plans cover it, while others exclude anti-obesity medications.

Major medical organizations recognize obesity as a chronic disease that may require ongoing treatment.

A properly licensed clinician may evaluate whether Wegovy is clinically appropriate and prescribe it when permitted. Insurance coverage still depends on plan rules.

Some Aetna plans may cover Wegovy, while others restrict or exclude it. Verify the current formulary and benefit rules.

Coverage varies among regional BCBS organizations and individual plans.

Some UHC plans may cover Wegovy when benefit and clinical criteria are met.

Some Cigna-administered plans include Wegovy, depending on employer benefits and plan design.

Common reasons include a benefit exclusion, incomplete records, unmet clinical criteria, or an incomplete prior authorization.

When appeal rights are available, additional records addressing the denial reason may be submitted.

These may be qualifying weight-related conditions under some plans, but requirements vary.

Some plans consider documented prediabetes during medical-necessity review.

Timing varies and may be longer if the insurer requests additional information.

Documented weight and treatment history may help explain ongoing medical need, but does not guarantee approval.

Plan-wide exclusions can be difficult to overturn. Review formal appeal rights and alternative benefit options.

Coverage may evolve as evidence, costs, regulations, and employer benefit decisions change, but expansion is not guaranteed.